A detailed history of Efg Asset Management (North America) Corp. transactions in Exact Sciences Corp stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 53,713 shares of EXAS stock, worth $2.66 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
53,713
Previous 58,896 8.8%
Holding current value
$2.66 Million
Previous $2.49 Million 46.99%
% of portfolio
0.62%
Previous 0.44%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$42.43 - $70.83 $219,914 - $367,111
-5,183 Reduced 8.8%
53,713 $3.66 Million
Q2 2024

Jul 25, 2024

SELL
$41.33 - $74.26 $865,326 - $1.55 Million
-20,937 Reduced 26.23%
58,896 $2.49 Million
Q1 2024

May 13, 2024

BUY
$56.27 - $73.77 $1.72 Million - $2.25 Million
30,565 Added 62.04%
79,833 $5.51 Million
Q4 2023

Feb 08, 2024

BUY
$59.06 - $75.72 $579,201 - $742,586
9,807 Added 24.85%
49,268 $3.64 Million
Q3 2023

Nov 02, 2023

BUY
$65.94 - $99.04 $90,469 - $135,882
1,372 Added 3.6%
39,461 $2.69 Million
Q2 2023

Jul 28, 2023

SELL
$62.68 - $95.05 $252,788 - $383,336
-4,033 Reduced 9.57%
38,089 $3.58 Million
Q1 2023

Apr 27, 2023

BUY
$47.19 - $70.77 $1.99 Million - $2.98 Million
42,122 New
42,122 $2.86 Million
Q2 2022

Aug 04, 2022

SELL
$35.61 - $76.23 $172,779 - $369,867
-4,852 Reduced 6.93%
65,117 $2.57 Million
Q1 2022

Apr 26, 2022

BUY
$57.56 - $82.54 $482,928 - $692,510
8,390 Added 13.62%
69,969 $4.89 Million
Q4 2021

Feb 18, 2022

BUY
$72.5 - $100.68 $4.46 Million - $6.2 Million
61,579 New
61,579 $4.8 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.77B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Efg Asset Management (North America) Corp. Portfolio

Follow Efg Asset Management (North America) Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (North America) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (North America) Corp. with notifications on news.